217 related articles for article (PubMed ID: 16220066)
1. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity: roles of endothelium, phosphodiesterase, and K+ channel.
Wu BN; Chen IC; Lin RJ; Chiu CC; An LM; Chen IJ
J Cardiovasc Pharmacol; 2005 Nov; 46(5):600-8. PubMed ID: 16220066
[TBL] [Abstract][Full Text] [Related]
2. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
3. KMUP-1 relaxes rabbit corpus cavernosum smooth muscle in vitro and in vivo: involvement of cyclic GMP and K(+) channels.
Lin RJ; Wu BN; Lo YC; Shen KP; Lin YT; Huang CH; Chen IJ
Br J Pharmacol; 2002 Mar; 135(5):1159-66. PubMed ID: 11877322
[TBL] [Abstract][Full Text] [Related]
4. KMUP-1, a xanthine derivative, induces relaxation of guinea-pig isolated trachea: the role of the epithelium, cyclic nucleotides and K+ channels.
Wu BN; Lin RJ; Lo YC; Shen KP; Wang CC; Lin YT; Chen IJ
Br J Pharmacol; 2004 Aug; 142(7):1105-14. PubMed ID: 15237094
[TBL] [Abstract][Full Text] [Related]
5. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitric oxide release and expression of cGMP and protein kinase G.
Lin RJ; Wu BN; Lo YC; An LM; Dai ZK; Lin YT; Tang CS; Chen IJ
J Pharmacol Exp Ther; 2006 Feb; 316(2):709-17. PubMed ID: 16234412
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
Komas N; Lugnier C; Stoclet JC
Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
[TBL] [Abstract][Full Text] [Related]
10. KMUP-1 activates BKCa channels in basilar artery myocytes via cyclic nucleotide-dependent protein kinases.
Wu BN; Tu HF; Welsh DG; Chen IJ
Br J Pharmacol; 2005 Nov; 146(6):862-71. PubMed ID: 16151435
[TBL] [Abstract][Full Text] [Related]
11. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
12. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
[TBL] [Abstract][Full Text] [Related]
13. Contribution of K+ channels and ouabain-sensitive mechanisms to the endothelium-dependent relaxations of horse penile small arteries.
Prieto D; Simonsen U; Hernández M; García-Sacristán A
Br J Pharmacol; 1998 Apr; 123(8):1609-20. PubMed ID: 9605568
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
15. Evidence that potassium channels make a major contribution to SIN-1-evoked relaxation of rat isolated mesenteric artery.
Plane F; Hurrell A; Jeremy JY; Garland CJ
Br J Pharmacol; 1996 Dec; 119(8):1557-62. PubMed ID: 8982501
[TBL] [Abstract][Full Text] [Related]
16. The role of NO-cGMP pathway and potassium channels on the relaxation induced by clonidine in the rat mesenteric arterial bed.
Pimentel AM; Costa CA; Carvalho LC; Brandão RM; Rangel BM; Tano T; Soares de Moura R; Resende AC
Vascul Pharmacol; 2007 May; 46(5):353-9. PubMed ID: 17258511
[TBL] [Abstract][Full Text] [Related]
17. The anti-diabetic drug repaglinide induces vasorelaxation via activation of PKA and PKG in aortic smooth muscle.
Kim HW; Li H; Kim HS; Shin SE; Jung WK; Ha KS; Han ET; Hong SH; Choi IW; Firth AL; Bang H; Park WS
Vascul Pharmacol; 2016 Sep; 84():38-46. PubMed ID: 27435474
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
19. Labedipinedilol-C: a third-generation dihydropyridine-type calcium channel antagonist displaying K+ channel opening, NO-dependent and adrenergic antagonist activities.
Yeh JL; Liou SF; Liang JC; Lee CH; Chiu CC; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2005 Aug; 46(2):130-40. PubMed ID: 16044023
[TBL] [Abstract][Full Text] [Related]
20. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery.
Dong H; Waldron GJ; Cole WC; Triggle CR
Br J Pharmacol; 1998 Mar; 123(5):821-32. PubMed ID: 9535009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
